Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Congenital Cytomegalovirus Infection in Children with Autism Spectrum Disorder: Systematic Review and Meta-Analysis.
Maeyama K, Tomioka K, Nagase H, Yoshioka M, Takagi Y, Kato T, Mizobuchi M, Kitayama S, Takada S, Nagai M, Sakakibara N, Nishiyama M, Taniguchi-Ikeda M, Morioka I, Iijima K, Nishimura N. Maeyama K, et al. Among authors: nishimura n. J Autism Dev Disord. 2018 May;48(5):1483-1491. doi: 10.1007/s10803-017-3412-x. J Autism Dev Disord. 2018. PMID: 29185167
A polymorphic mutation, c.-3279T>G, in the UGT1A1 promoter is a risk factor for neonatal jaundice in the Malay population.
Yusoff S, Takeuchi A, Ashi C, Tsukada M, Ma'amor NH, Zilfalil BA, Yusoff NM, Nakamura T, Hirai M, Harahap IS, Gunadi, Lee MJ, Nishimura N, Takaoka Y, Morikawa S, Morioka I, Yokoyama N, Matsuo M, Nishio H, van Rostenberghe H. Yusoff S, et al. Among authors: nishimura n. Pediatr Res. 2010 Apr;67(4):401-6. doi: 10.1203/PDR.0b013e3181d22f78. Pediatr Res. 2010. PMID: 20057336
Diagnosis of spinal muscular atrophy via high-resolution melting analysis symmetric polymerase chain reaction without probe: a screening evaluation for SMN1 deletions and intragenic mutations.
Morikawa S, Harahap IS, Kaszynski RH, Yamamoto T, Pramudya DK, Pham HT, Hartomo TB, Lee MJ, Morioka I, Nishimura N, Yokoyama N, Ueno Y, Matsuo M, Nishio H. Morikawa S, et al. Among authors: nishimura n. Genet Test Mol Biomarkers. 2011 Oct;15(10):677-84. doi: 10.1089/gtmb.2010.0237. Epub 2011 Jun 1. Genet Test Mol Biomarkers. 2011. PMID: 21631299
Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells.
Nishimura N, Hartomo TB, Pham TV, Lee MJ, Yamamoto T, Morikawa S, Hasegawa D, Takeda H, Kawasaki K, Kosaka Y, Yamamoto N, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Iijima K, Matsuo M, Nishio H. Nishimura N, et al. Environ Health Prev Med. 2012 May;17(3):246-51. doi: 10.1007/s12199-011-0239-5. Epub 2011 Sep 10. Environ Health Prev Med. 2012. PMID: 21909813 Free PMC article.
Rab15 alternative splicing is altered in spheres of neuroblastoma cells.
Pham TV, Hartomo TB, Lee MJ, Hasegawa D, Ishida T, Kawasaki K, Kosaka Y, Yamamoto T, Morikawa S, Yamamoto N, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Iijima K, Matsuo M, Nishio H, Nishimura N. Pham TV, et al. Among authors: nishimura n. Oncol Rep. 2012 Jun;27(6):2045-9. doi: 10.3892/or.2012.1731. Epub 2012 Mar 15. Oncol Rep. 2012. PMID: 22427180
The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.
Yamamoto N, Nishimura N, Takeuchi M, Ito T, Yokozaki H, Hirase S, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Nishio H, Matsuo M, Imadome K, Iijima K. Yamamoto N, et al. Among authors: nishimura n. Eur J Pediatr. 2014 Dec;173(12):1615-8. doi: 10.1007/s00431-013-2181-6. Epub 2013 Oct 30. Eur J Pediatr. 2014. PMID: 24169729
Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia.
Hirase S, Hasegawa D, Takahashi H, Moriwaki K, Saito A, Kozaki A, Ishida T, Yanai T, Kawasaki K, Yamamoto N, Kubokawa I, Mori T, Hayakawa A, Nishimura N, Nishio H, Iijima K, Kosaka Y. Hirase S, et al. Among authors: nishimura n. Int J Hematol. 2015 Nov;102(5):594-601. doi: 10.1007/s12185-015-1875-0. Epub 2015 Oct 6. Int J Hematol. 2015. PMID: 26440971 Clinical Trial.
Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients.
Yamamoto N, Kozaki A, Hartomo TB, Yanai T, Hasegawa D, Kawasaki K, Kosaka Y, Matsuo M, Hirase S, Mori T, Hayakawa A, Iijima K, Nishio H, Nishimura N. Yamamoto N, et al. Among authors: nishimura n. Oncol Lett. 2015 Nov;10(5):3228-3232. doi: 10.3892/ol.2015.3710. Epub 2015 Sep 16. Oncol Lett. 2015. PMID: 26722317 Free PMC article.
1,364 results